These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25220079)

  • 1. BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels.
    Fisher PM; Holst KK; Adamsen D; Klein AB; Frokjaer VG; Jensen PS; Svarer C; Gillings N; Baare WF; Mikkelsen JD; Knudsen GM
    Hum Brain Mapp; 2015 Jan; 36(1):313-23. PubMed ID: 25220079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF val66met association with serotonin transporter binding in healthy humans.
    Fisher PM; Ozenne B; Svarer C; Adamsen D; Lehel S; Baaré WF; Jensen PS; Knudsen GM
    Transl Psychiatry; 2017 Feb; 7(2):e1029. PubMed ID: 28195567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.
    Kraus C; Baldinger P; Rami-Mark C; Gryglewski G; Kranz GS; Haeusler D; Hahn A; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
    PLoS One; 2014; 9(9):e106810. PubMed ID: 25188405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.
    Klein AB; Trajkovska V; Erritzoe D; Haugbol S; Madsen J; Baaré W; Aznar S; Knudsen GM
    J Cereb Blood Flow Metab; 2010 Nov; 30(11):e1-7. PubMed ID: 20736957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypes do not confer risk for delinquency but rather alter susceptibility to positive and negative environmental factors: gene-environmentinteractions of BDNF Val66Met, 5-HTTLPR, and MAOA-uVNTR [corrected].
    Nilsson KW; Comasco E; Hodgins S; Oreland L; Åslund C
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humans.
    Fisher PM; Holst KK; Mc Mahon B; Haahr ME; Madsen K; Gillings N; Baaré WF; Jensen PS; Knudsen GM
    Neuroimage; 2012 Aug; 62(1):130-6. PubMed ID: 22584237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study.
    Jaworska N; MacMaster FP; Foster J; Ramasubbu R
    BMC Psychiatry; 2016 Mar; 16():61. PubMed ID: 26976307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BDNF Val66Met and serotonin transporter 5-HTTLPR polymorphisms on psychopathological characteristics in a sample of university students.
    Kourmouli N; Samakouri M; Mamatsiou A; Trypsianis G; Livaditis M; Veletza S
    Psychiatr Genet; 2013 Oct; 23(5):188-97. PubMed ID: 23884433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 5-HTTLPR and BDNF Val66Met polymorphisms on neurostructural changes in major depressive disorder.
    Han KM; Choi S; Kim A; Kang J; Won E; Tae WS; Kim YK; Lee MS; Ham BJ
    Psychiatry Res Neuroimaging; 2018 Mar; 273():25-34. PubMed ID: 29414128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overnight retention of emotional memories is influenced by BDNF Val66Met but not 5-HTTLPR.
    Harrington MO; Klaus K; Vaht M; Harro J; Pennington K; Durrant SJ
    Behav Brain Res; 2019 Feb; 359():17-27. PubMed ID: 30321558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serotonin transporter promoter and BDNF Val66Met genotype on personality traits in a population representative sample of adolescents.
    Hiio K; Merenäkk L; Nordquist N; Parik J; Oreland L; Veidebaum T; Harro J
    Psychiatr Genet; 2011 Oct; 21(5):261-4. PubMed ID: 21206400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function.
    Wang L; Ashley-Koch A; Steffens DC; Krishnan KR; Taylor WD
    Genes Brain Behav; 2012 Apr; 11(3):352-9. PubMed ID: 22225729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter and BDNF genetic variants interact to predict cognitive reactivity in healthy adults.
    Wells TT; Beevers CG; McGeary JE
    J Affect Disord; 2010 Oct; 126(1-2):223-9. PubMed ID: 20398943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
    Grabe HJ; Schwahn C; Mahler J; Appel K; Schulz A; Spitzer C; Fenske K; Barnow S; Freyberger HJ; Teumer A; Petersmann A; Biffar R; Rosskopf D; John U; Völzke H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):264-70. PubMed ID: 21996278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
    Gruber O; Hasan A; Scherk H; Wobrock T; Schneider-Axmann T; Ekawardhani S; Schmitt A; Backens M; Reith W; Meyer J; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):23-31. PubMed ID: 21509595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between the combined genotypes of 5-HTTLPR and BDNF Val66Met polymorphisms and parenting on adolescent depressive symptoms: A three-year longitudinal study.
    Wang M; Tian X; Zhang W
    J Affect Disord; 2020 Mar; 265():104-111. PubMed ID: 32090731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive effect of 5-HTTLPR and BDNF polymorphisms on amygdala intrinsic functional connectivity and anxiety.
    Loewenstern J; You X; Merchant J; Gordon EM; Stollstorff M; Devaney J; Vaidya CJ
    Psychiatry Res Neuroimaging; 2019 Mar; 285():1-8. PubMed ID: 30711709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism.
    Terracciano A; Tanaka T; Sutin AR; Deiana B; Balaci L; Sanna S; Olla N; Maschio A; Uda M; Ferrucci L; Schlessinger D; Costa PT
    Neuropsychopharmacology; 2010 Apr; 35(5):1083-9. PubMed ID: 20042999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.